RNA Tag m6A Emerges as a Master Switch in Gene Control, Stress and Disease

N6-methyladenosine, an internal chemical tag on RNA in eukaryotic cells, is the focus of a review published in Nature Reviews Molecular Cell Biology. Written by Zihong Kang, Feng Zhang, Guo-li Ming, Hongjun Song, Jun Liu and colleagues, the article synthesises how this single modification precisely regulates gene expression at the RNA level, and how its dysregulation has been implicated in neurodegenerative disease and cancer.

A central theme of the review is that m6A deposition is not random. The authors describe how the chromatin environment, the act of transcription itself, and RNA processing steps jointly govern where the mark is placed along transcripts. This multilayered control means that m6A patterns reflect the state of the genome and the cell’s transcriptional activity, coupling epigenetic regulation directly to the fate of RNA molecules.

Once deposited, the modification is interpreted by a coordinated molecular machinery. Enzymes known as writers install m6A, erasers remove it, and reader proteins recognise the mark and translate it into functional outcomes. According to the review, these outcomes include altered chromatin function as well as changes in RNA splicing, stability, localisation within the cell and translation into protein.

The authors argue that this dynamic regulatory network enables cells to adapt to environmental changes. They illustrate how m6A orchestrates cellular stress responses, helping cells adjust gene expression when conditions shift, and how it contributes to metabolic homeostasis. The review also connects the modification to antitumour immunity, indicating that m6A regulation influences how tumour cells interact with the immune system.

Pathological consequences feature prominently in the analysis. Dysregulation of the m6A machinery has been implicated in brain disorders, including neurodegenerative diseases, and in cancer. By dissecting how writers, erasers and readers normally cooperate, the review offers a framework for understanding how their malfunction may contribute to disease processes.

Looking toward the clinic, the authors highlight translational prospects of m6A biology. These include the development of specific small-molecule inhibitors that could target the enzymes controlling the modification, and precise RNA editing technologies that could correct aberrant m6A patterns. The review also addresses the remaining challenges for clinical interventions targeting m6A, underscoring that translating mechanistic insights into therapies remains a work in progress.

As a review article, the publication does not present new experimental data but consolidates the current state of a fast-moving field. Its significance lies in framing m6A as a hub that connects chromatin regulation, RNA processing and cellular physiology, offering researchers a roadmap for studying the modification in health and disease.

Subject of Research: The RNA modification N6-methyladenosine and its roles in gene regulation, cellular responses and disease

Article Title: Molecular functions, cellular responses and pathological implications of the RNA modification N6-methyladenosine

Article References: Kang, Z., Zhang, F., Ming, G.-L., Song, H., & Liu, J. (2026). Molecular functions, cellular responses and pathological implications of the RNA modification N6-methyladenosine. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/s41580-026-01039-y

Image Credits: AI Generated

DOI: 10.1038/s41580-026-01039-y

Keywords: m6A, RNA modification, gene expression, epitranscriptomics, writers and erasers, reader proteins, cancer, neurodegenerative disease, antitumour immunity, chromatin regulation, RNA editing, small-molecule inhibitors